Cargando…

Telomerase Activation in Hematological Malignancies

Telomerase expression and telomere maintenance are critical for cell proliferation and survival, and they play important roles in development and cancer, including hematological malignancies. Transcriptional regulation of the rate-limiting subunit of human telomerase reverse transcriptase gen (hTERT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ropio, Joana, Merlio, Jean-Philippe, Soares, Paula, Chevret, Edith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039560/ https://www.ncbi.nlm.nih.gov/pubmed/27618103 http://dx.doi.org/10.3390/genes7090061

Ejemplares similares

Reliable blood cancer cells' telomere length evaluation by qPCR
por: Ropio, Joana, et al.
Publicado: (2020)

Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas
por: Chebly, Alain, et al.
Publicado: (2022)

The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
por: Wang, Limengmeng, et al.
Publicado: (2014)

The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies
por: Yamada, Osamu, et al.
Publicado: (2013)

Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas
por: Ropio, Joana, et al.
Publicado: (2023)

Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas
por: Chebly, Alain, et al.
Publicado: (2021)

hMZF-2, the Elusive Transcription Factor
por: Chebly, Alain, et al.
Publicado: (2020)

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma
por: Gros, Audrey, et al.
Publicado: (2017)

Telomerase-targeted therapies in myeloid malignancies
por: Waksal, Julian A., et al.
Publicado: (2023)

Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy.
por: Burger, A. M., et al.
Publicado: (1997)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Telomerase activity in benign and malignant human thyroid tissues.
por: Cheng, A. J., et al.
Publicado: (1998)

Assays for Detection of Telomerase Activity
por: Skvortsov, D.A., et al.
Publicado: (2011)

Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas
por: Merlio, Jean-Philippe, et al.
Publicado: (2021)

Monitoring NK cell activity in patients with hematological malignancies
por: Viel, Sébastien, et al.
Publicado: (2013)

Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

The treatment of hematologic malignancies in pregnancy
por: Vandenbriele, C., et al.
Publicado: (2010)

Rac GTPases in Hematological Malignancies
por: Durand-Onaylı, Valerie, et al.
Publicado: (2018)

Arterial stiffness in hematologic malignancies
por: Mozos, Ioana, et al.
Publicado: (2017)

Checkpoint inhibitors in hematological malignancies
por: Ok, Chi Young, et al.
Publicado: (2017)

HMGA Proteins in Hematological Malignancies
por: Minervini, Angela, et al.
Publicado: (2020)

Chromosome Territories in Hematological Malignancies
por: de Lima, Matheus Fabiao, et al.
Publicado: (2022)

Intestinal Microbes and Hematological Malignancies
por: Zhu, Yinghong, et al.
Publicado: (2023)

Mitochondrial transfer in hematological malignancies
por: Guo, Xiaodong, et al.
Publicado: (2023)

Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse
por: Remes, K, et al.
Publicado: (2000)

Human Telomerase RNA: Telomerase Component or More?
por: Rubtsova, Maria, et al.
Publicado: (2020)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells
por: Chebly, Alain, et al.
Publicado: (2021)

Telomerase and its extracurricular activities
por: Jaiswal, Rishi Kumar, et al.
Publicado: (2013)

‘Leaky gut’ in hematological malignancies()
por: Costa-Lima, Carolina, et al.
Publicado: (2014)

Ethical and Clinical Aspects of Intensive Care Unit Admission in Patients with Hematological Malignancies: Guidelines of the Ethics Commission of the French Society of Hematology
por: Malak, Sandra, et al.
Publicado: (2014)

The Hematology of Tomorrow Is Here—Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
por: Arranz, Lorena
Publicado: (2022)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Hematological Malignancies and Arterial Thromboembolism
por: Visweshwar, Nathan, et al.
Publicado: (2019)

Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
por: Fan, Hueng-Chuen, et al.
Publicado: (2019)

CircRNAs in hematopoiesis and hematological malignancies
por: Bonizzato, A, et al.
Publicado: (2016)

Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues
por: Chang, J T-C, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_o4nutul18vj44vt27gp6n544r3